Retinoblastoma Protein and Bladder Cancer Treatment
Author Information
Author(s): Agerbaek M, Alsner J, Marcussen N, Lundbeck F, von der Maase H
Primary Institution: Aarhus University Hospital
Hypothesis
Is retinoblastoma protein expression an independent predictor of radiation response and survival in muscle-invasive bladder cancer?
Conclusion
The study found that loss of retinoblastoma protein expression is associated with increased radiosensitivity and poorer survival outcomes in muscle-invasive bladder cancer.
Supporting Evidence
- Complete response to preoperative radiotherapy was found in 40% of patients with residual tumor.
- Loss of pRB expression was observed in 37% of tumors.
- Absence of pRB immunostaining was a significant predictor of complete response to radiotherapy.
Takeaway
This study shows that a protein called retinoblastoma can help doctors understand how well bladder cancer patients will respond to radiation treatment.
Methodology
The study included 108 patients with invasive bladder cancer who received preoperative radiotherapy followed by radical cystectomy, with data collected from patient files and tumor biopsies.
Potential Biases
Potential biases include selection bias due to the retrospective nature and the limited generalizability of findings to other populations.
Limitations
The study is retrospective and may have biases related to patient selection and treatment protocols.
Participant Demographics
Patients were consecutive individuals with invasive transitional cell bladder cancer treated at Aarhus University Hospital from 1980 to 1992.
Statistical Information
P-Value
0.004
Confidence Interval
1.57–10.53
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website